Literature DB >> 21319870

Treatment of viral conjunctivitis with antiviral drugs.

Chrysanthi L Skevaki1, Ioanna E Galani, Michail V Pararas, Konstantina P Giannopoulou, Athanassios Tsakris.   

Abstract

Viral conjunctivitis is one of the most common disorders observed in ophthalmic emergency departments, yet no established treatment exists. Lately, antiviral medications have been introduced into clinical practice; however, a systematic review focusing on their use and effectiveness in the treatment of viral conjunctivitis has not been previously reported. We systemically reviewed the literature to identify studies where antiviral drugs were used to treat viral conjunctivitis. Currently, aciclovir, trifluridine and valaciclovir are commonly used as antiviral agents to treat herpesvirus infections. Cidofovir has been used successfully to treat some cases of adenoviral conjunctivitis, although toxicity has also been reported. The use of other medications, such as idoxuridine, has been minimized in clinical practice due to their high toxicity. Interestingly, most of the antiviral drugs developed are used to treat herpesvirus infections, while less progress has been made in the field of adenoviral infections. For other viral causes of conjunctivitis, no effective remedy is currently available, and treatment focuses on the relief of symptoms. Caution should be exercised when coadministering other pharmacological agents, such as corticosteroids, because of emerging adverse effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21319870     DOI: 10.2165/11585330-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  81 in total

1.  Topical human fibroblast interferon for acute adenoviral conjunctivitis.

Authors:  K R Wilhelmus; E C Dunkel; J Herson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

2.  Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis.

Authors:  Eiichi Uchio; Aki Fuchigami; Kazuaki Kadonosono; Akio Hayashi; Hiroaki Ishiko; Koki Aoki; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-17       Impact factor: 3.117

Review 3.  Viruses and apoptosis.

Authors:  V O'Brien
Journal:  J Gen Virol       Date:  1998-08       Impact factor: 3.891

4.  An outbreak of acute conjunctivitis caused by coxsackievirus A24 in Kuala-Lumpur, Malaysia, 1978.

Authors:  D S Tan; M Yin-Murphy; S Kandiah
Journal:  Southeast Asian J Trop Med Public Health       Date:  1980-03       Impact factor: 0.267

5.  A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.

Authors:  J S Pelletier; K Stewart; W Trattler; D C Ritterband; S Braverman; C M Samson; B Liang; J A Capriotti
Journal:  Adv Ther       Date:  2009-08       Impact factor: 3.845

6.  Inhibition of the enteroviruses that cause acute hemorrhagic conjunctivitis (AHC) by benzimidazoles; enviroxime (LY 122772) and enviradone (LY 127123).

Authors:  M P Langford; W A Ball; J P Ganley
Journal:  Antiviral Res       Date:  1995-08       Impact factor: 5.970

7.  Molecular epidemiology of coxsackie A type 24 variant in Taiwan, 2000-2007.

Authors:  Pei-Yu Chu; Guan-Ming Ke; Cheng-Hsien Chang; Jou-Chun Lin; Chung-Yi Sun; Wen-Loong Huang; Yen-Chin Tsai; Liang-Yin Ke; Kuei-Hsiang Lin
Journal:  J Clin Virol       Date:  2009-05-26       Impact factor: 3.168

8.  Parinaud's oculoglandular syndrome due to herpes simplex virus type 1.

Authors:  Fulvio Parentin; Gianna Dal Molin; Pierlanfranco D'Agaro; Marina Busetti; Cesare Campello
Journal:  Ocul Immunol Inflamm       Date:  2007 Mar-Apr       Impact factor: 3.070

Review 9.  The epidemiology and clinical presentation of herpes virus infections.

Authors:  C Stuart-Harris
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

10.  Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model.

Authors:  Seth P Epstein; Yevgenia Y Pashinsky; David Gershon; Irene Winicov; Charlie Srivilasa; Katarina J Kristic; Penny A Asbell
Journal:  BMC Ophthalmol       Date:  2006-06-05       Impact factor: 2.209

View more
  10 in total

Review 1.  Conjunctivitis: a systematic review of diagnosis and treatment.

Authors:  Amir A Azari; Neal P Barney
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

Review 2.  Ocular tropism of respiratory viruses.

Authors:  Jessica A Belser; Paul A Rota; Terrence M Tumpey
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

Review 3.  Innate immunity to adenovirus.

Authors:  Rodinde Hendrickx; Nicole Stichling; Jorien Koelen; Lukasz Kuryk; Agnieszka Lipiec; Urs F Greber
Journal:  Hum Gene Ther       Date:  2014-04-08       Impact factor: 5.695

4.  Identification of genotoxic compounds using isogenic DNA repair deficient DT40 cell lines on a quantitative high throughput screening platform.

Authors:  Kana Nishihara; Ruili Huang; Jinghua Zhao; Sampada A Shahane; Kristine L Witt; Stephanie L Smith-Roe; Raymond R Tice; Shunichi Takeda; Menghang Xia
Journal:  Mutagenesis       Date:  2015-08-04       Impact factor: 3.000

5.  Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.

Authors:  Kazuki Sakamoto; Tatsushi Yokogawa; Hiroyuki Ueno; Kei Oguchi; Hiromi Kazuno; Keiji Ishida; Nozomu Tanaka; Akiko Osada; Yukari Yamada; Hiroyuki Okabe; Kenichi Matsuo
Journal:  Int J Oncol       Date:  2015-04-20       Impact factor: 5.650

6.  Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.

Authors:  Nozomu Tanaka; Kazuki Sakamoto; Hiroyuki Okabe; Akio Fujioka; Keisuke Yamamura; Fumio Nakagawa; Hideki Nagase; Tatsushi Yokogawa; Kei Oguchi; Keiji Ishida; Akiko Osada; Hiromi Kazuno; Yukari Yamada; Kenichi Matsuo
Journal:  Oncol Rep       Date:  2014-09-17       Impact factor: 3.906

7.  Regulation of Human Adenovirus Replication by RNA Interference.

Authors:  N A Nikitenko; T Speiseder; E Lam; P M Rubtsov; Kh D Tonaeva; S A Borzenok; T Dobner; V S Prassolov
Journal:  Acta Naturae       Date:  2015 Jul-Sep       Impact factor: 1.845

Review 8.  Update on overview of ocular manifestations of COVID-19.

Authors:  Mitra Akbari; Maryam Dourandeesh
Journal:  Front Med (Lausanne)       Date:  2022-09-13

9.  Comparative study on the efficacy of non-steroidal, steroid and non-use of anti-inflammatory in the treatment of acute epidemic conjunctivitis.

Authors:  Luiz Alfredo Santiago; Jussara Matyelle Rodrigues da Silva; Orleâncio Gomes Ripardo de Azevedo; Paulo Roberto Leitão de Vasconcelos
Journal:  Acta Cir Bras       Date:  2020-02-07       Impact factor: 1.388

10.  Pentavalent Sialic Acid Conjugates Block Coxsackievirus A24 Variant and Human Adenovirus Type 37-Viruses That Cause Highly Contagious Eye Infections.

Authors:  Emil Johansson; Rémi Caraballo; Nitesh Mistry; Georg Zocher; Weixing Qian; C David Andersson; Daniel L Hurdiss; Naresh Chandra; Rebecca Thompson; Lars Frängsmyr; Thilo Stehle; Niklas Arnberg; Mikael Elofsson
Journal:  ACS Chem Biol       Date:  2020-09-16       Impact factor: 5.100

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.